A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions. (Q35936893)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15521793%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15521793%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

4 January 2020

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15521793%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Patrick W Sullivan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15521793%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Robert Valuck

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15521793%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Holly M MacFall

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15521793%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15521793%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15521793%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15521793%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15521793%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

911-932

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15521793%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00023210-200418130-00006

4 January 2020

exact match

0 references

cites work

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

1 reference

12 December 2020

Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France

1 reference

12 December 2020

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

1 reference

12 December 2020

Escitalopram: a pharmacoeconomic review of its use in depression

1 reference

12 December 2020

Effect of antidepressant therapy on health care utilization and costs in primary care.

1 reference

12 December 2020

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

1 reference

12 December 2020

Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices.

1 reference

12 December 2020

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

1 reference

12 December 2020

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

1 reference

12 December 2020

Paroxetine. A pharmacoeconomic evaluation of its use in depression

1 reference

12 December 2020

Selective versus multi-transmitter antidepressants: are two mechanisms better than one?

1 reference

12 December 2020

Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials.

1 reference

12 December 2020

Fluoxetine. A pharmacoeconomic review of its use in depression

1 reference

12 December 2020

Problems and solutions in calculating quality-adjusted life years (QALYs)

1 reference

12 December 2020

Third-generation antidepressants: do they offer advantages over the SSRIs?

1 reference

12 December 2020

Cost implications of initial antidepressant selection in primary care

1 reference

12 December 2020

Handling uncertainty in cost-effectiveness models

1 reference

12 December 2020

EuroQol: health-related quality of life measurement. Results of the Swedish questionnaire exercise

1 reference

12 December 2020

Sertraline. A pharmacoeconomic evaluation of its use in depression

1 reference

12 December 2020

The economic burden of depression in the United States: how did it change between 1990 and 2000?

1 reference

12 December 2020

Formulary restriction of selective serotonin reuptake inhibitors for depression: potential pitfalls

1 reference

12 December 2020

Cost effectiveness of representatives of three classes of antidepressants used in major depression in the UK.

1 reference

12 December 2020

1 reference

12 December 2020

Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease

1 reference

12 December 2020

Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors.

1 reference

12 December 2020

SSRIs versus other antidepressants for depressive disorder

1 reference

12 December 2020

Absenteeism among employees treated for depression.

1 reference

12 December 2020

Modeling valuations for EuroQol health states

1 reference

12 December 2020

Modeling for health care and other policy decisions: uses, roles, and validity

1 reference

12 December 2020

Determinants of antidepressant treatment compliance: implications for policy.

1 reference

12 December 2020

Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another?

1 reference

12 December 2020

Assessing the economic impact of adverse drug effects

1 reference

12 December 2020

Medicare program; physician fee schedule update for calendar year 2003. Final rule

1 reference

12 December 2020

Relationship between medication errors and adverse drug events

1 reference

12 December 2020

Cost of treatment failure for major depression: direct costs of continued treatment

1 reference

12 December 2020

Tolerability and adherence issues in antidepressant therapy

1 reference

12 December 2020

The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report

1 reference

12 December 2020

Cost-effective treatment of depression with selective serotonin reuptake inhibitors.

1 reference

12 December 2020

An elementary introduction to Bayesian computing using WinBUGS.

1 reference

12 December 2020

Economic appraisal of citalopram in the management of single-episode depression

1 reference

12 December 2020

The impact of treatment-resistant depression on health care utilization and costs

1 reference

12 December 2020

Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association

1 reference

12 December 2020

A comparison of methods for analyzing health-related quality-of-life measures.

1 reference

12 December 2020

Primer on Medical Decision Analysis: Part 3—Estimating Probabilities and Utilities

1 reference

12 December 2020

The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population.

1 reference

12 December 2020

A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitor. Comparison of cost-effectiveness between escitalopram, citalopram, fluoxetine, and venlafaxine for the treatment of depression in Norway

1 reference

12 December 2020

Censoring in statistical models of health status: what happens when one can do better than '1'.

1 reference

12 December 2020

Discontinuing or switching selective serotonin-reuptake inhibitors

1 reference

12 December 2020

Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence

1 reference

12 December 2020

The economic burden of depression in 1990.

1 reference

12 December 2020